Cerecin forges strategic partnership with A*STAR’s Institute of Molecular and Cell Biology (IMCB) in Singapore to advance R&D in neurological disorders. | Macau Business

[ad_1] Cerecin and IMCB signed a Memorandum of Understanding to collaborate in the areas of neurometabolism, neurodegeneration, metabolic regulators, and brain health and function. SINGAPORE and DENVER, Dec. 1, 2023 /PRNewswire/…

Cerecin forges strategic partnership with A*STAR’s Institute of Molecular and Cell Biology (IMCB) in Singapore to advance R&D in neurological disorders.

[ad_1] Cerecin and IMCB signed a Memorandum of Understanding to collaborate in the areas of neurometabolism, neurodegeneration, metabolic regulators, and brain health and function. SINGAPORE and DENVER, Nov. 30, 2023 /PRNewswire/…

Tapping into digital therapeutics to improve neurological outcomes –

[ad_1] Image Credit: Shutterstock / Pixels Hunter As the field of digital therapeutics continues to broaden, specific uses in mental health and neurology are increasingly making headway for patients and…